Brachytherapy

Royal Surrey treat landmark 5,000th patient with brachytherapy

Doctors at Royal Surrey NHS Foundation Trust have treated their 5,000th prostate cancer patient with brachytherapy.

Brachytherapy is an alternative treatment to more conventional surgeries, which consists of radioactive ‘seeds’ implanted in or completely covering the prostate gland tumour.

The treatment is considered to have less side effects as the radiation is inserted directly into the prostate, meaning any healthy tissue in the nearby vicinity gets a lower dose of radiation – ultimately reducing the amount of collateral damage dealt.

Professor Stephen Langley, who treated the first and 5,000th brachytherapy patients at Royal Surrey, said: “For the right patient, brachytherapy is as effective as surgery but with fewer side effects. The radioactive material only affects the tissue very close to it, so it tackles the tumour without harm to the rest of the body.

“Our published curative rates for brachytherapy are more than 90% for most cancers, with more than 99% of patients retaining urinary continence and more than 80% of men retaining erectile function.”

Royal Surrey were one of the first hospitals to trial brachytherapy in the UK back in 1999 and have become just the second site in the world to treat more than 5,000 patients using the technique.

Professor Langley added: “Royal Surrey pioneered brachytherapy treatment more than two decades ago and, today, patients from all over Europe come to receive brachytherapy with us.”

Royal Surrey is one of the UK’s primary providers of cancer care – it serves not only their own local community but operates as a regional referral centre in the South East, and in some cases, nationally too.

Richard, a hospital consultant working in the West Country, happened to be the 5,000th brachytherapy patient to be treated at Royal Surrey. After Richard’s prostate cancer became malignant and started to grow – after four years of dormancy – he sought treatment at Royal Surrey.

He said: “I chose brachytherapy because it has fewer side effects than the surgery for my condition and a good treatment success rate for my diagnosis. After hearing Professor Langley’s reputation in the field, I asked if he could treat me at Royal Surrey. 

“The brachytherapy team couldn’t have been more helpful and the procedure went well. I came out feeling surprisingly fine. A week on, I can now feel that the brachytherapy implants are active which is slightly uncomfortable but I believe this feeling should subside within the next few weeks and I am hopeful this treatment will be successful.”

More information about brachytherapy and Royal Surrey’s landmark 5,000th patient is available here.

NHE

NHE Issue 102

Join the conversation shaping the future of healthcare.

Click below to read more!

More articles...

View all
Online conferences

Presenting

2025 Online Conferences

In partnership with our community of health sector leaders responsible for delivering the UK's health strategy across the NHS and the wider health sector, we’ve devised a collaborative calendar of conferences and events for industry leaders to listen, learn and collaborate through engaging and immersive conversation. 

All our conferences are CPD accredited, which means you can gain points to advance your career by attending our online conferences. Also, the contents are available on demand so you can re-watch at your convenience.

National Health Executive Podcast

Listen to industry leaders on everything within healthcare

Whether it's the latest advancements in medical technology, healthcare policies, patient care innovations, or the challenges facing healthcare providers, we cover it all.

 

Join us as we engage with top healthcare professionals, industry leaders, and policy experts to bring you insightful conversations that matter.